Abstract
Some peculiarities of the erythrocytes of newborn infants are now well documented. The best known are their high hemoglobin F concentration and their shortened life span of about 80 days (I, 2). Clinically most important is the susceptibility of newborn infants, especially of prematures, to develop hemolytic anemia, characterized by Heinz bodies within the red cells, or methemoglobinemia on exposure to a variety of agents (Reviews see 3, 4). The mechanism of this high susceptibilty, mainly, against oxidizing drugs, has been the subject of numerous studies in the past 20 years. The examination of the erythrocytes of newborn infants has been stimulated especially by the introduction of enzymology. Due to the relative homogeneity and availability of erythrocyte suspensions and their comparatively small number of metabolic pathways, the biochemical characterization of the human erythrocyte is more accomplished than that of most other human tissues. The developmental variations of the erythrocyte enzyme activities are well known too. But all these more descriptive studies do not definitely explain why the erythrocytes of newborn infants live only 80 instead of 120 days and why these cells are highly vulnerable to oxidizing agents.
This work was supported by research grants (Schr 86/6, Schr 86/7) of the Deutsche Forschungsgemeinschaft, Bad Godesberg, Germany.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
GARBY L., S. Sjölin and J. Vuille, (1964) Acta paediat. (Uppsala) 53: 165.
Pearson H. A., (1967) J. Pediat. 70: 166.
KLEIHAUER E., (1966) Fetales Hämoglobin und fetale Erythrocyteri, Ferdinand Enke Verlag, Stuttgart.
OSKI F. A. and J. L. NAIMAN, (1966) Hematologic problems in the newborn, W. B, Saunders, Philadelphia and London.
BEUTLER E., (1966) Amer. J. Med.41: 724.
HüRTER P., W. SCHRöTER, I. SCHEDEL and G. GERCKEN, (1970) Pediatrics46: 259.
OSKI F. A., (1967) Pediatrics39: 689.
OSKI F. A. and J. L. NAIMAN, (1965) Pediatrics36: 103.
SCHRöTER W. and H. von HEYDEN, (1965) Z• Kinderheilk.94: 263.
SCHRöTER W. and P. WINTER, (1967) Klin. Wschr. 45: 255.
WITT I., H. MüLLER and W. KüNZER, (1967) Klin. Wschr.45: 262.
WITT I., M. HERDAN and W. KüNZER, (1968) Klin. Wschr.46: 149.
SCHRöTER W., (1969) In: Enzymopenic Anaemias, Lysosomes and Other papers, ALLAN J. D., K. S. HOLT, J. T. IRELAND and R. J. POLLITT, eds., Livingstone, Edinburgh and London, p. 19.
OSKI F. A. and Gh. SMITH, (1968) Pediatrics41: 473.
WHAUN J. M. and F. A. OSKI, (1969) Pediat. Res.3: 105.
BLUM S. F. and F. A. OSKI, (1969) Pediatrics43: 396.
DANON Y., A. KLEIMANN and D. DANON, (1970) Acta haemat. 43: 242.
SJöLIN S., (1954) Acta paediat.(Uppsala), Suppl. 98, 43: 390.
BETKE K. and E. Kleihauer, (1958) Blut4: 241.
Ross J. D., (1963) Blood21: 51.
BETKE K., (1953) Naturwissenschaften40: 60.
ALLEN D. W. and J. H. JANDL, (1961) J. clin. Invest.40: 454.
WEED R., J. EBER and A. ROTHSTEIN, (1961) J. gen. Physiol. 45: 395.
VANSTEVENINCK J., R. I. WEED and A. ROTHSTEIN, (1965) J. gen. Physiol.45: 617.
KOSOWER N. S., (1968) In: Hereditary disorders of erythrocyte metabolism, E. Beutler ed., Grune & Stratton, New York and London, p. 176.
JACOB H. S., S. H. INGBAR and J. H. JANDL, (1965) J. clin. wp&tf. 44: 1187.
ZINKHAM W. H., (1959) Pediatrics23: 18.
28.SCHRöTER W., (1968) Dtsch. med. WFOAR. 93: 1202.
GROSS R. T., R. BRACCI, N. RUDOLPH, E. SCHROEDER and J. A. KOCHEN, (1967) Blood29: 481.
VETRELLA M., W. BARTHELMAI and J. RIETKöTTER, (1970) Klin. Wschr.48: 85.
WHAUN J. and F. A. OSKI, (1970) J. Pediat.76: 555.
HILL A. S., A. HAUT, G. E. GARTWRIGHT and M. M. WINTROBE, (1964) J. clin. Invest.43: 17.
JACOB H. S. and S. E. Lux, IV, (1968) Blood32: 549.
BEUTLER E., O. DURON and M. KELLY, (1963) J. Lab. clin. Med.61: 882.
WEED R. I. and G. F. REED, (1966) Am. J. Med.41: 681.
CROWLEY J., P. WAYS and J. W.JONES, (1965) J. clin. Invest.44: 989.
NEERHOUT R. C., (1968) Pediat. Res.2: 172.
DERVICHIAN D., G. FOURNET, A. GUINIER and E.PONDER, (1952) Rev. Hemat.7: 567.
SACHTLEBEN V. P., H. LEHMANN and G.RUHENSTROTH-BAUER (1961) Blut 7:
369.
HOLLAN S. R., J. G. SZELENYL, J. H. BREUER, V. MEDGYESI and G. N. SöTER (1968) Folia haemat.(Lpzg.) 90: 125.
CENTURY B. and M. K. HORWITT, (i960) J. Nutrition72: 357.
LEWIS S. E. and E. D. WILLS, (1962) Biochem. Pharmacol.11: 60.
SCHRöTER W. and K. BITTER, (1969) Klin. Wschr.47: 727.
JACOB H. S. and J. H. JANDL, (1962) J. clin. Invest.41: 779.
Schröter W. and H. Bodemann, (1970) Biol. Neonat.15: 291.
LINDEMANN B. and H. PASSOW, (i960) Pflügers Arch. ges. Physiol. 271: 497.
OSKI F. A. and L. A. BARNES, (1967) J. Pediat. 70: 211.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1971 H. E. Stenfert Kroese N.V. Leiden Holland
About this chapter
Cite this chapter
Schröter, W. (1971). Drug Susceptibility and the Development of Erythrocyte Enzyme Systems. In: Jonxis, J.H.P., Visser, H.K.A., Troelstra, J.A. (eds) Metabolic Processes in the Foetus and Newborn Infant. Nutricia Symposium, vol 3. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-2951-3_6
Download citation
DOI: https://doi.org/10.1007/978-94-010-2951-3_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-2953-7
Online ISBN: 978-94-010-2951-3
eBook Packages: Springer Book Archive